MedTrace Logo

Commercial Lidocaine Patch as a Treatment for Ear-ringing

NCT02088866 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2017-05-30

No results posted yet for this study

Summary

The purpose of this investigation is to evaluate if topically applied lidocaine, in the form of lidocaine patches, reduces the burden of chronic subjective tinnitus in a consistent and measurable way.

Conditions

  • Tinnitus

Interventions

DRUG

Transdermal Lidocaine

The intervention will use 5% commercially available transdermal lidocaine in clinical practice for the treatment of tinnitus. This dose will be tailored to patient preference.

Sponsors & Collaborators

  • University of California, Davis

    lead OTHER

Principal Investigators

  • Daniel C O'Brien, B.S. · University of California Davis Department of Medical Education

  • Rodney Diaz, MD · University of California Davis Department of Otolaryngology - Head and Neck Surgery

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2015-08-31
Completion
2015-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02088866 on ClinicalTrials.gov